Product Information
TERBINAFINE HCL 250 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $0.1356 per EA under NDC 69452035113. Its NADAC has been published 207 times since Sep 7, 2022.
FDA first approved this application on Jul 2, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Bionpharma Inc.NDC
69452035113
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TERBINAFINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078163FDA Approved
7/2/2007
TE Code
AB
On Market Since
1/28/2022
Pharmacological Classes
Price Statistics
The NADAC for TERBINAFINE HCL 250 MG TABLET has been published 207 times since Sep 7, 2022, and over the history we have for it it has declined 14.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1356 per EA |
|---|---|
| All-time high | $0.1683 (Nov 16, 2022) |
| All-time low | $0.1158 (Nov 20, 2024) |
| 52-week high | $0.1513 |
| 52-week low | $0.1324 |
| Median price | $0.1505 |
| Average price | $0.1483 |
| Largest weekly change | -21.1% (Nov 20, 2024) |
| Weeks tracked | 207 |
| Tracking since | Sep 7, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TERBINAFINE HCL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TERBINAFINE HCL 250 MG TABLET, manufactured by Bionpharma Inc., is $0.1356 per EA (NDC 69452035113), effective Aug 19, 2026.
How has the price of TERBINAFINE HCL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for TERBINAFINE HCL 250 MG TABLET has declined 14.9%. It has been tracked across 207 weekly CMS publications since Sep 7, 2022.
What are the highest and lowest recorded NADAC prices for TERBINAFINE HCL 250 MG TABLET?
Since Sep 7, 2022, the NADAC for TERBINAFINE HCL 250 MG TABLET has ranged from a low of $0.1158 (Nov 20, 2024) to a high of $0.1683 (Nov 16, 2022), with a median of $0.1505 per EA.
Are there cheaper alternatives to TERBINAFINE HCL 250 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TERBINAFINE HCL 250 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TERBINAFINE HCL 250 MG TABLET?
TERBINAFINE HCL 250 MG TABLET (NDC 69452035113) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.